LMH STRATEGIC SOLUTIONS

Lobbying for NEUROCRINE BIOSCIENCES, INC. · Biopharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $10,000.00 income · posted Jul 21, 2025

Lobbying activity 2

Medicare/Medicaid

General Medicare and Medicaid Issues.

Pharmacy

Prescription drug payment reform. Pharmaceutical supply chain.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.